Diagnostics

Mayo Clinic’s Individualizing Medicine Conference explained, in tweets

Mayo Clinic's Individualizing Medicine conference this week touched on many of the most important trends in precision medicine. Here they are, as explained in tweets.

By Meghana Keshavan on September 23, 2015

Mayo Clinic is wrapping up its Individualizing Medicine Conference, which centered on the logistics of bringing precision medicine to the clinic. It was a Twitter-heavy affair – and the tweets managed to really capture the essence of what’s important today in precision medicine.

This is an overview of the conference trends, illustrated in tweets.

Discussing the impact of next-generation sequencing on precision medicine was particularly huge. Here is a telling slide from David Litwack of the FDA’s precision medicine team:

presented by

Related – everything about this slide is so important:

presented by

And this tweet says it all about the fields most important to advance if we’re going to make this precision medicine thing a reality, as told by Mayo Clinic VP Gianrico Farrugia:

J. Craig Venter keynoted, and spoke of his company, Human Longevity, and its new consumer-facing business that’ll allow individuals to access their medically relevant genetic information. On the lower end, users can have their exome sequenced for $250. Details of the high-end version can be seen in his slide here:

To which we get an honest reaction:

https://twitter.com/StevenNHart/status/646359563399114752

After all:

The audience was polled. About 3 percent disapprove of Scotland:

This makes sense when you consider the questionnaires in 23andMe and the personal data asks from Apple’s ResearchKit. They have huge implications for precision medicine:

https://twitter.com/StevenNHart/status/646003681733689344

This comes from Sage BioNetworks:

https://twitter.com/StevenNHart/status/646001660880289792

But I must say, this was a pretty accurate – and exciting – takeaway of the precision medicine conference: